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INTRODUCTION
G protein-coupled receptors (GPCRs) comprise a large family
of integral membrane proteins that mediate signal transduction
across the cell membrane.1 GPCRs are activated by a wide variety
of extracellular stimuli and interact primarily with G proteins to
trigger a cascade of responses inside the cell. The human genome
encodes about 800 GPCRs and they can be phylogenetically classi-
fied into five main classes, with the rhodopsin-like class A being
the largest with about 670 members.2,3 Members of this family
are important pharmaceutical targets because of their association
with numerous diseases,4 thus structural models of GPCRs have
useful applications in rational drug discovery.
It is believed that GPCRs share a common architecture of seven
transmembrane (TM) helices packed into a 7-TM helical bundle,
with three intracellular and three extracellular loops.5 Sequence
analysis shows that class A receptors can be characterized by a set
of highly conserved residues in each TM helix.6 Ligands for class
A GPCRs are chemically diverse, including photons, ions, biogenic
amines, nucleosides and nucleotides, peptides and protein hor-
mones, lipids and eicosanoids, and they bind mainly within a
pocket confined to the TM region and extracellular loops.7
Understanding the structural basis for how such a large diversity
of ligands is accommodated within a common TM helical bundle
architecture has been limited by a lack of structural information.
Experimental structure determination of membrane proteins is
technically challenging, and high-resolution structures are
available for only few members from the eukaryotic class A
GPCRs.8–19 Structural models predicted in silico can provide
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ABSTRACT
Building reliable structural models of G protein-
coupled receptors (GPCRs) is a difficult task
because of the paucity of suitable templates, low
sequence identity, and the wide variety of ligand
specificities within the superfamily. Template-based
modeling is known to be the most successful
method for protein structure prediction. However,
refinement of homology models within 1–3 Å Ca
RMSD of the native structure remains a major chal-
lenge. Here, we address this problem by developing
a novel protocol (foldGPCR) for modeling the
transmembrane (TM) region of GPCRs in complex
with a ligand, aimed to accurately model the struc-
tural divergence between the template and target in
the TM helices. The protocol is based on predicted
conserved inter-residue contacts between the tem-
plate and target, and exploits an all-atom implicit
membrane force field. The placement of the ligand
in the binding pocket is guided by biochemical
data. The foldGPCR protocol is implemented by a
stepwise hierarchical approach, in which the TM
helical bundle and the ligand are assembled by
simulated annealing trials in the first step, and the
receptor-ligand complex is refined with replica
exchange sampling in the second step. The protocol
is applied to model the human b2-adrenergic recep-
tor (b2AR) bound to carazolol, using contacts
derived from the template structure of bovine rho-
dopsin. Comparison with the X-ray crystal structure
of the b2AR shows that our protocol is particularly
successful in accurately capturing helix backbone
irregularities and helix-helix packing interactions
that distinguish rhodopsin from b2AR.
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insights to better understand ligand-binding specificity
and the activation mechanism of GPCRs.
Protein structure prediction methods, ranging from
homology modeling to de novo methods, have been
applied to the modeling of GPCRs. Before the first X-ray
crystal structure for a 7-TM receptor was solved, models
for bacteriorhodopsin and rhodopsin were built using a
low-resolution electron density map and restraints
derived from sequence analysis or biophysical experi-
ments.20–22 Mosberg et al. built models of 26 GPCRs by
distance geometry calculations based on interhelical
hydrogen bonds.23,24 After the rhodopsin structure was
solved in 2000, homology modeling and fragment-based
threading methods were applied to build models for
GPCRs using the rhodopsin structure as the tem-
plate.25,26 Ab initio approaches have also been applied
to model class A receptors.27,28 Within this set of tech-
niques, template-based modeling methods are arguably
the most reliable approach for predicting protein struc-
ture from amino acid sequence.29 However, the suitabil-
ity of the rhodopsin template to accurately predict the
structure of other GPCRs is questionable,30 as the aver-
age sequence identity to bovine rhodopsin of human
GPCRs is relatively low at 20%,26 and the GPCR
superfamily is highly diverse in its ligand-binding proper-
ties. Reliable homology models are less confidently
obtained as the sequence and structure similarity between
the template and target decrease.29,31 Although the over-
all helical bundle architecture is thought to be similar for
class A GPCRs, detailed structural features are expected
to differ for receptors binding to different ligands.
Indeed, the crystal structures of bovine rhodopsin and
human b2-adrenergic receptor (b2AR) bound to an antag-
onist show that the two structures are similar, with a 2.7 Å
Ca RMSD in the TM region, despite a relatively low
sequence identity of 23%.12 However, the structures also
show subtle differences in the position, rotational orienta-
tion, and kink angles of helices I, III, IV, V, and VI. Other
class A GPCRs will likely possess such subtle differences.
Effective use of multiple templates and successful
application of fragment-based modeling or model refine-
ment methods have greatly improved the accuracy of
homology models. Nonetheless, obtaining models closer
to the target than the template remains a major challenge
in comparative modeling methods.29,32 Alternatively,
recent progress in modeling of membrane proteins has
demonstrated that an implicit membrane generalized
Born (GB) force field, combined with advanced sampling
techniques, performs well in the study of folding and as-
sembly of membrane proteins, as well as in de novo
structure prediction and refinement of homology mod-
els.33–36 Implicit solvent force fields in general have also
been shown to be effective in refining NMR structures
with a limited number of experimental observables or
near-native decoys and predicted structures sufficiently
close to the native basin.37–39
This article describes a novel modeling approach
(foldGPCR) for predicting the structure of a class A
GPCR 7-TM helical bundle in complex with its ligand.
The protocol aims to accurately model the structural
divergence between the template and target in the TM
helices. Building on the idea of using secondary structure
and tertiary restraints to predict 3D structures, the proto-
col uses distance restraints derived from a template struc-
ture to impose the overall helical bundle topology and
conserved inter-residue contacts. Additional distance
restraints suggested mostly from experimental data are
imposed on receptor-ligand interactions to model the
ligand binding geometry. These restraints guide the con-
formational sampling process in simulated annealing tri-
als during the assembly of the helical bundle and the
ligand. The receptor-ligand complex model is then
refined in an implicit membrane GB force field with rep-
lica exchange (REX) sampling.
The intracellular and extracellular loops in GPCRs are
known to have important functional roles in ligand-bind-
ing and G-protein interaction,40 but they are challenging
to model accurately and are not modeled in the current
foldGPCR protocol. The crystal structures of rhodopsin
and b2AR show that the structure of the loop regions
can be vastly different, with the extracellular loop 2
(ECL2) forming a b sheet lid in rhodopsin, and a helix
in b2AR.8,12 The loop regions are more variable in
sequence and length,6 and also more dynamic and con-
formationally flexible than the TM regions,40 making
them difficult to predict by both homology modeling
and de novo modeling approaches.41,42 The recent com-
munity-wide assessment of GPCR structure modeling
also showed that the loop regions are significantly more
difficult than the TM regions to model accurately.43
The foldGPCR protocol is applied to model the
human b2AR bound to carazolol using contact restraints
derived from the bovine rhodopsin template. As a con-
trol, the protocol is also applied to model the bovine
rhodopsin using the same set of contact restraints. We
will report on the accuracy of the models obtained for
b2AR and rhodopsin, see Supporting Information for the
results on the rhodopsin models, then discuss some of
the key properties of the protocol and its strengths com-
pared with other GPCR modeling approaches.
METHODS
FoldGPCR: A protocol for GPCR TM
structure prediction
The foldGPCR method uses all-atom restrained molec-
ular dynamics, and is implemented in a stepwise hier-
archical manner, in which the helical bundle and the
ligand are assembled by simulated annealing trials using
tertiary restraints in the first step, and the receptor-ligand
complex is refined using an implicit membrane GB force
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field and REX sampling in the second step (see Fig. 1).
The protocol aims to accurately model the structural
divergence between the template and target in the TM
helices, by using tertiary restraints derived from the tem-
plate structure, while relying on an improved physics-
based force field to yield conformations capturing struc-
tural features unique to the target. The molecular dy-
namics simulations are performed using the CHARMM
program.44,45 We will first describe the two steps of the
foldGPCR method, and then give details of the distance
restraints used throughout the protocol.
Step 1: Assembly of the 7-TM helical bundle
Initial configuration
The seven TM helices are modeled independently as
disjoint helical segments. A canonical a-helix (w 5 257,
F 5 247; side chains are in extended conformations) is
built for each helix, then it is oriented perpendicularly to
the membrane plane (xy-plane), centered at the mid-
plane, z 5 0, and positioned around the perimeter of a
circle sequentially, with each helix axis displaced 25 Å
from the center of the circle [Fig. 2(A)]. The N-terminus
to C-terminus directionality of TM helices I, III, V, and
VII are flipped relative to TM helices II, IV, and VI to
reflect the membrane traversal directions of the helices in
the native helical bundle. The putative seven TM seg-
ments are obtained from a previously published multiple
sequence alignment of class A GPCRs.46 The alignment
was checked that the following conserved motifs are
aligned across the family: N1.50 in TM helix I, L2.46,
A2.47, D2.50 in TM helix II, D/E3.49, R3.50, Y3.51 in
TM helix III, W4.50 in TM helix IV, F5.47, P5.50, Y5.58
in TM helix V, F6.44, W6.48, P6.50 in TM helix VI,
N7.49, P7.50, Y7.53 in TM helix VII; the Ballesteros–
Weinstein numbering scheme is used to refer to resi-
dues.47 Helix lengths and boundaries are assumed to be
the same as rhodopsin. However, this assumption is not
an essential requirement for the protocol, and can be
substituted by predictions of the helical segments using
methods based on sequence information or potential
energy profiles.35
The ligand is positioned so that its center of mass is
approximately at the center of the circle and translated
vertically to the average z-coordinate of the residues used
in receptor-ligand distance restraints. The conformation
of the ligand is adopted from the crystal structures (PDB
ID code 1U19 for 11-cis-retinal bound to rhodopsin and
2RH1 for carazolol bound to b2AR). For other class A
receptors with no known ligand structure, the initial
ligand conformation can be built de novo before the
Figure 1
The foldGPCR protocol is implemented by a two-step hierarchical
approach, in which the 7-TM helical bundle and the ligand are
assembled in the first step, and the receptor-ligand complex is refined
in the second step.
Figure 2
FoldGPCR Step 1: Assembly of the helical bundle by simulated
annealing trials. (A) The cooling schedule and the coupled distance
scaling factor (2.0 to 1.0). (B) Energy versus Ca RMSD to the native
crystal structure is plotted for the ensemble of annealed structures
(dots) and the average structure (star) from a single modeling trial for
b2AR.
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annealing step by an additional step such as docking or
other conformational sampling techniques. LPDB
CHARMM parameters are used,48,49 and the atom types
of the ligands are assigned with the MATCH toolset
(Price and Brooks III, MATCH: primitive chemical pat-
tern-matching engine provides robust atom-typing tool-
set for molecular mechanics force fields, manuscript in
preparation). This initial 7-TM-ligand configuration is
minimized with 200 steps of mixed steepest descent and
adopted basis Newton–Raphson minimization using
positional harmonic restraints on all heavy atoms.
Simulated annealing protocol
The TM helical bundle is assembled by simulated
annealing trials in vacuum using a distance-dependent
dielectric function. The nonbonded interactions are
smoothly switched off from 6.5 Å to 8 Å. The conforma-
tional sampling in this step is focused on local interac-
tions within the helix and between adjacent helices, hence
short distance cutoffs are used to expedite the calcula-
tions. During each trial, the temperature is decreased
exponentially from 1000 to 300 K over 780 ps [Fig.
2(A)]. The cooling schedule is coupled to a gradually
decreasing distance scaling factor such that as the tem-
perature decreases from 1000 to 300 K, the distances
used in the restraint potentials are scaled by a factor of
2.0–1.0. Sampling time is maximized at distances where
the side chains of the helices are just coming into contact
but not yet tightly packed (scaling factor of 1.4), to
allow structural rearrangements necessary for sampling
alternative interhelical side chain packing interactions.
At the beginning of every annealing trial, each helix is
rotated about its axis and the ligand about the x-axis by
random angles. Each trial results in a single annealed
structure. For each modeling attempt, an ensemble of
200 annealed structures is generated. The tertiary
restraints are satisfied by nearly all of the annealed struc-
tures. The averaged structure is then minimized and
refined in the subsequent step.
The number of annealing trials per modeling attempt
was arbitrarily chosen so that the average structures from
any two distinct attempts would be within 1.0 Å Ca
RMSD from each other. The total length of the annealing
time was optimized with respect to the RMSD distribution
of the ensemble. The average structure is used as the initial
structure for refinement because it tends to be closer to
the native than any one structure in the ensemble [Fig.
2(B)]. The effect of averaging in increasing the level of
similarity to a given reference structure has previously
been demonstrated by Zagrovic and Pande.50 The averag-
ing process likely leads to a more native-like structure by
cancellation of random errors sampled in the ensemble.
Individual structural features usually occur with a unimo-
dal distribution in sampled ensemble, hence the average
structure represents the most populated conformation in
the ensemble. Distortions resulting from the averaging
process are largely corrected in the refinement step.
Step 2: All-atom refinement in
implicit membrane
Refinement protocol
The use of a GB implicit membrane model combined
with REX sampling has been shown to be effective in
obtaining native-like conformations in assembly and
refinement of TM proteins.33–36 The REX method is
known to enhance conformational sampling by simulat-
ing multiple replicas of the system at different tempera-
tures independently and simultaneously, and exchanging
pairs of replicas at neighboring temperatures at preset
intervals with a specified transition probability, allowing
random walks in temperature space to help replicas
escape from local energy minima.51,52 GB/REX refine-
ment is applied in the second step of foldGPCR to refine
the average structure from the simulated annealing trials.
An all-hydrogen CHARMM parameter set (PARAM22)
with the CMAP backbone torsional correction term is
used.53,54 The GB implicit membrane model imple-
mented in the GB model with a simple switching func-
tion (GBSW) module of CHARMM represents the mem-
brane environment as a low-dielectric slab.55 The mem-
brane thickness (Tmemb) is set to 35 Å, the membrane
switching length (msw) is set to 2.5 Å, the surface ten-
sion coefficient (g) is set to 0.04 kcal/(mol Å2), and other
parameters are set to default values. The values for Tmemb
and msw were chosen to match the hydrophobic thick-
ness of 31 Å estimated for rhodopsin in the OPM data-
base.56 The nonbonded interactions are switched off at
20 Å. The REX simulations are carried out using the
MMTSB toolset (www.mmtsb.org).57 We use 16 replicas
exponentially spaced between 300 and 450 K. Exchanges
between adjacent replicas are attempted once every pico-
second, with a total length of 500 ps. The exchange ac-
ceptance ratio ranged between 0.15 and 0.2. The energy
profile from the lowest temperature ensemble shows that
it converges within 500 ps [Fig. 3(A)]. The last 20% of
the structures (100 models) from the lowest temperature
ensemble are minimized and clustered based on Ca
RMSD to extract a few representative structures. Cluster-
ing was carried out with the MMTSB toolset using a Ca
RMSD-based hierarchical and divisive method.57 The av-
erage structures from all clusters as well as the average
structure of all 100 models are presented as the final pre-
dictions. The refinement step generally improves the
packing interaction of helices, thereby increases the frac-
tion of native contacts by 10% and lowers the overall
RMSD with respect to the native structure [Fig. 3(B)].
Distance restraints
Distance restraints are applied using a flat-bottom har-
monic potential function with a soft asymptote imple-
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mented in the NOE module of CHARMM. The flat-bot-
tom widths and the force constants for the harmonic
restraints were chosen so that the restraints would be
weakly imposed to allow sufficient structural flexibility
during the sampling procedure. These parameters were
chosen empirically, based on our previous experience with
protein structure refinement in implicit solvent,33,37 and
by trial-and-error. Three sets of distances are derived and
the corresponding restraints are applied with slightly dif-
ferent parameter values, as described below. The optimal
distances were estimated from known structures.
Topology of helical bundle
A set of 40 interhelical distances parallel to the mem-
brane plane at the top, middle, and bottom of the helical
bundle (z 5 0,  12 Å) is used to impose a particular
topology. This set of restraints mimics the use of low-reso-
lution cryo-EM structural data to approximate the spatial
organization of the helices without defining the position
of individual amino acids.21,58 The distance measure-
ments that define the relative positions and tilt angles of
the helices are obtained either from the b2AR (PDB ID
code 2RH1) or the rhodopsin (PDB ID code 1U19) crystal
structure.8,12 Each topological distance restraint is applied
between centers of mass of sets of four adjacent Ca atoms
from the two helices, to avoid biasing the rotational orien-
tations of the helices. The flat-bottom half width is set to
2.5 Å and the force constant is set to 5 kcal/(mol Å2).
Conserved inter-residue contacts
Structurally conserved inter-residue contacts are pre-
dicted by using sequence conservation as filters to select
from contacts present in the template rhodopsin struc-
ture (PDB ID code 1U19). The contact prediction
method is described elsewhere.59 Briefly, a contact in
rhodopsin is predicted to be structurally conserved in
another GPCR if the contact-forming residues or the
fragments around these residues are conserved in
sequence between the two sequences and across class A
GPCRs. Out of 183 interhelical contacts in the rhodopsin
TM region, 40–50 are typically predicted to be con-
served in another GPCR. The method predicts 45 con-
tacts for the human b2AR (Supporting Information Table
I). The restraints are applied between the side chain
heavy atoms (Ca atom for Gly) with distance summation
r ¼ ðPjðr6j ÞÞ1=6. The distance is set to 3.2  2.0 Å
(4.2  2.0 Å for pairs containing Gly) and the force con-
stant is set to 5 kcal/(mol Å2).
Receptor-ligand interactions
Specific receptor-ligand interactions, such as hydrogen
bonds are restrained to model the binding geometry of the
ligand. Although the topological and contact restraints are
derived directly from the template structure, the ligand
restraints are mostly derived from experiments, such as
mutagenesis studies that suggest particular residues are
involved in ligand-binding. The restraints are applied
between the side chain heavy atoms and particular func-
tional groups in the ligand. The distance is set to 3.5  0.5
Å, 3.0  0.5 Å, and 5.0  2.0 Å for salt bridge, hydrogen
bonding, and hydrophobic interactions, respectively. The
force constant is set to 50 kcal/(mol Å2). For the b2AR-
carazolol interaction, residues D1133.32, N3127.39, F2906.52,
S2035.42, Y3167.43, V1143.33, and W1093.28 are used; for the
rhodopsin-11-cis-retinal interaction, residues K2967.43,
E1133.28, W2656.48, F2125.47, and M2075.42 are used. In
modeling class A receptors with limited and ambiguous
experimental data on receptor-ligand interactions, several
different sets of ligand restraints may need to be tested
and optimized to obtain an average annealed model that
agrees well with the experimental data.
Additional restraints
The dihedral angles of the helices and the ligands are
restrained by weak harmonic potentials to minimize
Figure 3
FoldGPCR Step 2: Membrane GB/REX refinement of the receptor-
ligand complex. Energy profile of the lowest temperature ensemble (A)
and Ca RMSD profile for a replica that contributes to the last 100 ps
of the lowest temperature ensemble (B) during a 500 ps refinement run
from a modeling trial for b2AR.
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severe distortions at high temperature. The backbone tor-
sion angles of the helices are restrained near ideal values
but with significant latitude for fluctuation, w 5 257 
30, F 5 247  30 degrees. The dihedral angles of all ro-
tatable bonds in the ligand are restrained so that the
ligand conformation is maintained within 1.0 Å heavy
atom RMSD from the initial structure. In the case that
the receptor-bound ligand structure is not known, and
the initial ligand conformation is built de novo, the force
constants can be adjusted to allow sampling of other
ligand conformations.
RESULTS AND DISCUSSION
Accuracy of b2AR models
The foldGPCR protocol is applied to model the
human b2AR structure. In this section, we report the ac-
curacy of the b2AR models generated using contact
restraints derived from the rhodopin template, topologi-
cal restraints with distance measurements from the b2AR
template, and ligand conformation and restraints
obtained from the b2AR crystal structure. In a blind pre-
diction scenario, the protocol would be run without any
restraints derived from the high-resolution structure of
b2AR, but this realistic case would incorporate a spec-
trum of errors inherent in the source of each set of
restraints. The models described here represent the opti-
mal case in which the protocol is run with restraint sets
that are mostly correct. We report the accuracy of the
models generated without any restraints from the b2AR
template in the context of the discussion on how
the three restraint sets affect model accuracy in a later
section.
The predicted models are 2.0 Å Ca RMSD for the
TM helices and 1.0 Å heavy atom RMSD for the ligand
carazolol with respect to the b2AR crystal structure (PDB
ID code 2RH1). We ran three independent modeling tri-
als, and obtained representative models ranging from 2.0
to 2.9 Å Ca RMSD. The average model of the entire final
ensemble of refined models tends to be more accurate
and converged across repeated trials than the cluster av-
erage models; the ensemble average model is 2.1  0.06
Å Ca RMSD from native in the three trials. These mod-
els show that the overall topology of the helical bundle is
in good agreement with the crystal structure [Fig. 4(A)].
The ligand is positioned accurately in the binding pocket
and the binding geometry agrees well with the crystal
structure. The alkylamine and alcohol moieties of carazo-
lol make several hydrogen bonds with the D1133.32 and
N3127.39 side chains. N7 of the carbazole heterocycle
forms a hydrogen bond with the side chain hydroxyl of
S2035.42. The ‘‘hydrophobic sandwich’’ around the C8-to-
C13 ring of the carbazole heterocycle is formed by
V1143.33 and F2906.52.
Helix irregularities, such as kinks, twists, bends, and
bulges are modeled in near-native conformations. The
average backbone RMSD from the crystal structure for
each individual helix is < 2.0 Å for all seven helices.
Kinks induced by Pro residues are modeled well in heli-
ces II, V, VI, and VII. The models capture the varying
degree of kink angles induced by Pro residues. The lack
of kink in helix I because of the absence of a Pro residue
is also modeled accurately. Other backbone features, such
Figure 4
Accuracy of the predicted models for b2AR (A) and rhodopsin (B). The
models are superimposed to their respective crystal structures (PDB ID
codes 2RH1 for b2AR; 1U19 for rhodopsin). The model shown is the
average structure of the entire refined ensemble. Model (magenta);
crystal structure (blue).
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as the bulge in helix V, are successfully modeled. The
bulge in helix V is formed by a backbone hydrogen bond
between the carbonyl oxygen of I2055.44 and the amide
hydrogen of V2105.49, preceding P2115.50.
Helix-helix packing interactions are modeled particu-
larly well for helices I, II, III, and V. The average side
chain RMSD from the crystal structure is < 3.5 Å for
helix pairs I-II, II-III, III-V, VII-I and 3.5–4.5 Å for he-
lix pairs III-IV, V-VI, VI-VII. The close-packing of resi-
dues V541.53-I551.54-A762.47, I471.46-V481.47-G832.54, and
F712.42-V1263.45-I1273.46, and the interhelical hydrogen
bonds formed between highly conserved residues, S742.45-
T1233.42-W1584.50 and N511.50-D792.50-S3197.46, show
that the side chain packing interactions between helices I,
II, and III are captured accurately. Some of the correctly
modeled interactions overlap with the conserved contact
restraints imposed in the protocol. However, it is notable
that near-native interactions are also modeled in the ab-
sence of explicit restraints. The current protocol is able
to remodel 60% of the native contacts in the final pre-
dicted models using just 45 contacts, or 10% native
contacts. The majority of these native contacts are not
immediately adjacent to the restrained contacts; for the
b2AR/pred/struct models, on average 11% are from con-
tacts used in the restraints, 16% are within 1 residue of
those restrained contacts, and 17% are within 2 resi-
dues.
Accuracy of rhodopsin models
The performance of the foldGPCR protocol is assessed
on modeling the bovine rhodopsin structure using con-
tact restraints analogous to those predicted for b2AR,
topological restraints with distance measurements from
the rhodopsin template, and ligand conformation and
restraints obtained from the rhodopsin crystal structure.
Similarly to the b2AR models reported in the previous
section, these rhodopsin models represent the optimal
case in which the protocol is run with restraint sets that
are highly reliable.
The predicted models are 2.5 Å Ca RMSD for the
TM helices and 2.0 Å heavy atom RMSD for the ligand
11-cis-retinal with respect to the rhodopsin crystal struc-
ture. In the three repeated trials, representative cluster av-
erage models range from 2.4 to 2.9 Å Ca RMSD, and the
ensemble average model is 2.5  0.06 Å Ca RMSD. The
overall topology of the helical bundle agrees well with
the crystal structure [Fig. 4(B)]. Most of the ligand bind-
ing interactions are modeled accurately: the carboxylate
oxygen atoms of E1133.28 form salt bridges with the
Schiff base nitrogen atom of K2967.43; the indole ring of
W2656.48 comes close to the C13-methyl group; the poly-
ene chain and the b-ionone ring interact with side chains
from helices III (A1173.32, T1183.33), V (M2075.42,
F2125.47), and VI (Y2686.51, A2696.52). The ligand is posi-
tioned less deeply in the binding pocket, and residues at
the bottom of the pocket, for example, G1213.36 and
F2616.44, are not proximal to the ligand. In general, resi-
dues lining the ligand-binding pocket are positioned
accurately to within 1.0–1.5 Å heavy atom RMSD with
respect to the crystal structures.
Helix backbone irregularities are modeled accurately
for the Pro-induced kinks in helices VI and VII, and the
bulge in helix V. Helix II is modeled as a straight helix
and the kink induced by the Gly-Gly motif is not mod-
eled; the kink angle in helix I is slightly too large, per-
haps caused by the inaccuracy in helix II. The average
backbone RMSD from the crystal structure for each indi-
vidual helix is < 2.0 Å for helices III, IV, V, VI, VII,
and 2.3 Å for helices I and II.
Helix-helix packing interactions are modeled well for
helices III, IV, V, VI, and VII. The average side chain
RMSD from the crystal structure is < 3.5 Å for helix
pairs III-IV, III-V, VI-VII and 3.5–4.5 Å for helix pairs
I-II, II-III, V-VI, VII-I. The inaccuracy in helix packing
interactions for helix II, especially on the extracellular
side, is likely caused by the inaccuracy in the backbone
structure of helix II. The ‘‘knobs-into-holes’’ packing of
residues T1604.49-I1233.38-W1263.41-S1273.42-V1303.45 and
I2195.54-L1253.40-L1283.43-V1293.44-A1323.47 shows that
the interfaces between helices III, IV, and V are captured
accurately.
The role of the restraints on model accuracy
The conformational search process in the assembly
step of the protocol is guided by distance restraints that
impose the helical bundle topology, inter-residue con-
tacts, and receptor-ligand interactions. These restraints
effectively reduce the conformational search space so that
sufficiently accurate models can be generated with the
current sampling protocol, and although more extensive
sampling may improve the overall structure in the pres-
ence of the restraints, the nature of the underlying force
field and representation of the environment will likely
limit such models to Ca RMSD values of 2 Å (based
on unrestrained simulations of the native GPCR struc-
tures). The three restraint sets are hierarchical in nature
and operate at different scales: the topological restraints
are coarsest and impose a general topology, analogous to
the use of restraints based on lower resolution cryo-EM
structural data,21,58 the contact restraints are analogous
to the NOE-like restraints used in NMR structure calcu-
lations and guide the packing interaction of secondary
structural elements; the ligand-side chain interaction
restraints are at the finest scale and determine the side
chain orientation and rotamer state of ligand-binding
residues. Because the three restraint sets contribute to the
models at different scales, it is expected that the errors
incorporated in them would have distinct effects on the
accuracy of the predicted models. To better understand,
the role of each restraint set to model accuracy, we ran a
FoldGPCR: Structure Prediction Protocol
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series of control modeling trials for b2AR using different
combinations of restraint sets with varying levels of
errors (Table I). In applying this protocol to modeling
other members of class A GPCRs, for which the reliabil-
ity of the restraint sets may be unknown, it is important
to assess the performance of the protocol given these
errors. The resulting models are described below and
organized around discussion of each restraint set.
The ligand interaction restraints guide the placement
of the ligand within the binding pocket and the confor-
mation of the side chains of the ligand-binding residues.
Models generated with and without the ligand are com-
parable in backbone accuracy, 2.0–2.5 Å Ca RMSD
from native, but the average side chain heavy atom
RMSD of residues within 4 Å of the ligand increases
from 2.7 Å for models with the ligand to 4.1 Å for mod-
els without the ligand. Models generated with a smaller
set of ligand interaction restraints (restraint sets b2AR/
pred/mut), using those just inferred from mutagenesis
data, are also comparable in backbone accuracy to mod-
els generated with restraint sets b2AR/pred/struct, but the
average heavy atom RMSD of binding site residue side
chains increases to 3.6 Å. Although models that agree
well with experimental data may be generated, these
models show that the side chain accuracy of the binding
site residues is quite sensitive to the ligand restraints
used in the protocol, suggesting that an erroneous set of
restraints may lead to models with inaccurate ligand
placement. The biochemical data used to infer ligand
restraints thus needs to be carefully selected for those
showing direct interactions between the receptor residues
and the ligand. Experiments, such as affinity labeling and
photo-crosslinking or functional complementation stud-
ies would be more informative than site-directed muta-
genesis studies.60
The topological restraints impose the topology of the
overall helical bundle without restricting on the rota-
tional orientations of the helices. Models built with topo-
logical restraints alone (restraint sets b2AR/-/-) are 4.0–
4.5 Å Ca RMSD from native, and have <20% native
contacts. Models generated without the topological
restraints (restraint sets -/pred/struct) are about 3.0 Å
Ca RMSD from native. In these models, the tilt angles of
helices tend to be less accurate. Models generated with
topological distance measurements from the rhodopsin
template (restraint sets Rhod/pred/struct) are 3.0 Å Ca
RMSD from native, and are worse than models generated
with restraint sets b2AR/pred/struct. These models are
2.5 Å Ca RMSD from the rhodopsin structure, and
hence, are closer to the rhodopsin template than to
b2AR. Although the topology of the rhodopsin and the
b2AR structures are similar, and the topological distance
measurements from the two structures are mostly within
2.5 Å of one another (Supporting Information Table
III), there is one distance between TM helices I and VII
on the extracellular side that differs as much as 5 Å
between the two structures because of the lack of Pro-
induced kink in helix I of b2AR. Substituting this one
distance measurement for the native distance (restraint
sets Rhod*/pred/struct) results in models that are 2.0 Å
Ca RMSD from native, and comparable in accuracy to
the b2AR/pred/struct models. These models show that the
topological distance measurements need to be accurate
within 5 Å, and any shifts in helix position of >5 Å
Table I
Accuracy of the b2AR Models Generated with Different Sets of
Restraints for Each of the Three Types of Restraints: Topological,
Contacts, and Ligand
Restraint
type Models Step 1: Assembly
Step 2:
Refinement
Topology Rhod/pred/struct 3.4  4.7 (199) 2.9  1.2 (100)
3.1  0.5 (36)
3.2  0.6 (30)
3.1  0.4 (24)
3.0  0.4 (10)
Rhod*/pred/struct 3.1  4.9 (197) 1.9  1.1 (100)
1.9  0.5 (66)
2.5  0.5 (27)
2.3  0.5 (7)
-/pred/struct 4.3  6.9 (199) 2.9  1.3 (100)
3.2  0.5 (32)
3.2  0.5 (31)
3.0  0.5 (29)
2.8  0.3 (8)
Contacts b2AR/all/struct 2.2  2.4 (198) 2.3  0.7 (100)
2.3  0.5 (71)
2.2  0.5 (29)
b2AR/correct/struct 1.6  3.4 (198) 1.8  0.9 (100)
1.9  0.5 (35)
2.1  0.5 (34)
1.8  0.5 (31)
b2AR/-/struct 3.8  6.1 (67) 3.5  1.0 (100)
3.5  0.6 (87)
3.8  1.4 (13)
b2AR/-/- 4.8  7.0 (87) 4.1  2.0 (100)
4.5  0.6 (54)
4.7  0.6 (30)
4.2  0.4 (16)
Ligand b2AR/pred/struct 2.7  4.9 (190) 2.0  1.0 (100)
2.0  0.6 (63)
2.5  0.8 (37)
b2AR/pred/mut 2.9  4.9 (197) 2.2  1.5 (100)
2.9  0.7 (42)
2.3  0.7 (37)
2.6  0.5 (21)
b2AR/pred/- 2.9  5.3 (86) 2.4  1.2 (100)
2.6  0.5 (42)
2.5  0.6 (32)
2.6  0.7 (26)
Topological restraints: b2AR (all distance measurements are from the b2AR crystal
structure), Rhod (all distance measurements are from the rhodopsin crystal struc-
ture), Rhod* (same as Rhod, except the distance between TM helices I and VII on
the extracellular side is from the b2AR structure),—(not used); Contact restraints:
pred (predicted conserved contacts),—(not used), correct (true conserved con-
tacts), all (unfiltered set of contacts from the template structure).Ligand restraints:
struct (obtained from the b2AR crystal structure), mut (inferred from mutagenesis
data),—(ligand is not modeled, ligand restraints are not used). Model accuracy is
reported as the Ca RMSD (Å) of the ensemble or cluster average structure from
the crystal structure (PDB ID codes 2RH1 for b2AR; 1U19 for rhodopsin)  Ca
RMS fluctuation (Å) around the average structure after each step of the protocol,
with the number of models in the ensemble or cluster in brackets.
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would be difficult to model accurately. Receptors, lacking
a Pro residue in helix I, are likely to be better modeled
using the distance measurements from the b2AR template
than the rhodopsin template.
The contact restraints guide the helix-helix packing
interactions. Models generated without contact restraints
(restraint sets b2AR/-/struct) are 3.5 Å Ca RMSD from
native. In these models, helix packing interactions are
not modeled very accurately and the fraction of native
contacts is 35%, significantly lower than 60% native
contacts achieved in the b2AR/pred/struct models. The
contact restraints are derived from a subset of contacts in
the rhodopsin template that are predicted to be structur-
ally conserved. Using the entire set of contacts from rho-
dopsin (restraint sets b21AR/all/struct) results in models
that are overall slightly less accurate than the b2AR/pred/
struct models, especially in the tilt angle of helix I,
because contacts with respect to the extracellular side of
helix I are not structurally conserved between b2AR and
rhodopsin. The distribution and accuracy of the pre-
dicted conserved contacts may affect how well different
regions of the helical bundle are modeled. Although the
accuracy of predicted contacts is expected to be high in
general,59 two of the 45 predicted contacts for b2AR are
clear false positives and both involve residues in helix IV.
Some of the contacts between helix IV and other helices
in rhodopsin are not formed in b2AR, because helix IV
in b2AR is shifted farther away from the binding site
compared to rhodopsin. These false positive contact
restraints may have led to the less accurate side chain
packing interactions between helices III and IV in the
b2AR/pred/struct models. Using the true conserved con-
tacts (restraint sets b2AR/correct/struct) results in models
that are slightly more accurate than the b2AR/pred/struct
models (Table III). The majority of the predicted con-
served contacts are on the cytoplasmic side of the helical
bundle owing to the higher level of sequence conserva-
tion towards this half of the helical bundle.6 The contacts
formed in this region may undergo significant rearrange-
ments upon receptor activation,61 hence the template
structure from which the contact restraints are derived
likely determines the conformational state of model.
Highlights of the foldGPCR protocol in
comparison to other approaches
We find that helices I, II, III, and V in our b2AR mod-
els are modeled particularly well, as indicated by an aver-
age Ca RMSD of 1.4 Å. The lack of kink in helix I, and
the bend angles in helices II, III, and V are captured
accurately. The packing interactions for helices II, III,
and V are modeled much closer to the b2AR structure
than to the rhodopsin template, with an average Ca
RMSD of 1.4 Å to b2AR and 1.8 Å to rhodopsin (see
Fig. 5), and improved from the rhodopsin template,
which differs by 2.1 Å Ca RMSD to the b2AR structure
in helices II, III, and V.
In comparison with other structure prediction meth-
ods that have previously been applied to model
b2AR,23,26,62 our current protocol appears to more
accurately model the backbone divergence between the
target and the best available template (Table II). TASSER
models (C-score: 1.4, template: 1F88_A) are 1.0 Å Ca
RMSD to rhodopsin, and do not recapitulate the struc-
tural features unique to b2AR: the bend angles in helices
I, III, V, and the packing interactions for helices II, III,
and V are not improved much from the rhodopsin tem-
plate. Although the TASSER method is reported to often
refine structures closer to native,63 the improvement rel-
ative to the template for the b2AR models seems rather
small. The de novo models generated by the MembStruk
method and the Mosberg distance geometry approach
are in general further away from both b2AR and rhodop-
sin. The MembStruk model captures the lack of kink in
helix I, but the backbone of helix III is distorted and the
rotational orientation and the vertical alignment of helix
V are inaccurate. The Mosberg model shows some trends
towards the native b2AR structure, in that the bend angle
in helix III is native-like, but helix V is positioned too
close to the center of the receptor.
The foldGPCR protocol is designed to optimize inter-
actions within and between the helices using tertiary
restraints combined with an improved physics-based
force field, and an efficient hierarchical sampling strategy.
To investigate the independent contributions to model
accuracy of the use of conserved contact restraints in the
assembly step and the GB implicit membrane model in
the refinement step, we ran modeling trials with i) a
homology model generated by Modeller31 instead of the
foldGPCR assembled model, and ii) refinement in vac-
uum instead of the GB implicit membrane model (Table
III). The homology model refined with GB/REX results
in models of 2.0 Å Ca RMSD and 60% native con-
tacts, and are comparable in overall accuracy to the
foldGPCR b2AR/pred/struct models, although helices II,
III, and V are more accurate in the foldGPCR models.
Models refined in vacuum are 3.0 Å Ca RMSD, and
are clearly worse than models refined with the GB
implicit membrane model. These trials demonstrate that
the assembly step using the conserved contact restraints
and the refinement step using the GB implicit membrane
model both contribute to model accuracy.
The protocol can be used to predict divergent struc-
tural features for GPCRs of unknown structure. We
applied the protocol to model the human vasopressin
V1a receptor (Swiss-Prot ID: P37288), human j-type
opioid receptor (Swiss-Prot ID: P41145), and human
proton-sensing receptor GPR4 (Swiss-Prot ID: P46093).
These receptors belong to the b-, g-, and d-groups of
class A GPCRs, respectively; and they may be structurally
more divergent from the templates than any receptors in
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the a-group. The superposition of the predicted models
to their respective template structures shows that there
may be numerous differences in the way the TM helices
are packed in these receptors (Supporting Information
Figure 1). For instance, helix II in the vasopressin V1a
receptor model lacks a kink despite the P1072.60 residue,
and allows the extracellular segment of helix I, that is
known to participate in agonist-binding,64 to be posi-
tioned closer to the binding site. Similarly, the extracellu-
lar segment of helix II in the j-type opioid receptor
model is slightly rotated and positions V1182.63, a residue
known to participate in agonist-binding,65 closer to the
binding pocket. Helix V in the proton-sensing GPR4 re-
ceptor model does not have a bulge at the helix center,
and consequently the extracellular segment of helix V is
slightly rotated.
Taken together, the main advantage of the foldGPCR
protocol is that it has the ability to accurately model the
structural divergence between the template and target,
and capture some of the structural features unique to the
target. A caveat is in the case of modeling receptors that
are close homologs to the template structure, for instance
in modeling b1AR based on b2AR. The structures of tur-
key b1AR and human b2AR differ only by 0.7 Å Ca
RMSD in the TM region.18 The foldGPCR models for
the human b1AR based on the b2AR structure is at best
1.7 Å Ca RMSD from the turkey b1AR structure, and
these models would be expected to be worse than homol-
ogy models based on b2AR. Nevertheless, for template-
target pairs with significant structural divergence such as
b2AR and rhodopsin, the foldGPCR protocol seems to
be able to generate better models than the homology
modeling approach.
Another advantage of the foldGPCR protocol is that it
is very flexible in incorporating additional or different
sets of distance restraints. The stepwise assembly and GB/
REX refinement approach is effective in generating mod-
els of reasonable accuracy given certain template- and
Figure 5
Modeling the structural divergence between rhodopsin and b2AR for
helices II, III, and V. The b2AR model (magenta) generated by the
restraint sets b2AR/pred/struct (see Table I for annotation) is
superimposed to the rhodopsin (green) and the b2AR (blue) crystal
structures using backbone atoms of helices II, III, and V.
Table II
Comparison of Model Accuracy for the b2AR Models Generated











Mosberg de novo 3.4/2.5
MembStruk 4.0/4.4
Model accuracy is reported as the Ca RMSDs (Å) for all seven TM helices and
for TM helices II, III, V from the b2AR crystal structure (PDB ID code 2RH1).
The ensemble average models from the three trials are shown for the foldGPCR
models. For the TASSER models, those with RMSD to native of below 6.5 Å are
shown.
Table III
Independent Contributions to Model Accuracy of the Use of Conserved
Contact Restraints in the Assembly Step, and the GB Implicit
Membrane Model in the Refinement Step
Step 1: Rough model generation Step 2: Refinement
FoldGPCR assembly GB implicit membrane
b2AR/pred/struct 2.0  1.0 (100)/1.2/1.8
2.7  4.9 (190)/2.4/2.6 2.0  0.6 (63)/1.3/1.7
b2AR/correct/struct GB implicit membrane
1.8  0.9 (100)/1.4/1.4
1.6  3.4 (198)/1.3/1.4 1.9  0.5 (35)/1.6/1.7
2.1  0.5 (34)/1.6/1.7
1.8  0.5 (31)/1.3/1.4
b2AR/all/struct GB implicit membrane
2.3  0.7 (100)/1.5/2.1
2.2  2.4 (198)/1.6/2.1 2.3  0.5 (71)/1.5/2.2
2.2  0.5 (29)/1.5/2.1
b2AR/pred/struct Vacuum
2.7  4.9 (190)/2.4/2.6
3.0  1.7 (100)/2.2/2.8
3.3  0.8 (50)/2.8/3.1
3.0  0.7 (37)/2.0/2.8
3.6  0.6 (13)/2.9/3.6
Rhodopsin-based homology model GB implicit membrane
2.1/2.2/2.2
2.0  1.5 (100)/2.0/2.0
2.7  0.4 (34)/2.9/2.7
2.3  0.4 (23)/2.1/2.2
2.8  0.4 (22)/2.5/2.8
2.1  0.4 (21)/1.2/2.1
Model accuracy for the b2AR models is reported as the Ca RMSD (Å) for all
seven TM helices as well as partially (all seven TM helices/helices II, III, V/all heli-
ces except helix VI). The b2AR homology model based on the rhodopsin template
was generated by Modeller.31
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experimentally-derived distance restraints. The protocol
provides a framework to generate receptor-ligand com-
plex models for GPCRs using any arbitrary set of sparse
distance restraints that define the topology of the helical
bundle, inter-residue contacts, and receptor-ligand inter-
actions. Restraint sets derived from another template,
multiple templates, or other biochemical or biophysical
experiments may be incorporated or substituted given
that there is a sufficient number of restraints to yield
converged models. For example, one interesting applica-
tion would be to generate an agonist-bound receptor
model using the recent crystal structures of opsin, which
show structural features of an active state,16,17 together
with distance measurements suggested from EPR experi-
ments.66
CONCLUSIONS
We have developed a novel modeling protocol
(foldGPCR) for predicting the structure of the class A
GPCR 7-TM helical bundle in complex with a ligand.
The protocol aims to accurately model the structural
divergence between the template and target in the TM
helices, by using tertiary restraints and an all-atom
implicit membrane GB force field to yield conformations
capturing structural features unique to the target. It is
implemented by a stepwise hierarchical approach, in
which the TM helical bundle and the ligand are
assembled by simulated annealing trials in the first step,
and then the receptor-ligand complex is refined with
REX sampling in the second step. The protocol is applied
to modeling the human b2AR bound to carazolol using
contact restraints derived from the bovine rhodopsin
template, and models with 2.0 Å Ca RMSD from the
b2AR crystal structure are obtained. Although the overall
accuracy is comparable to homology models obtained
with limited refinement, we find that some helical shifts
can be modeled much closer to the b2AR structure than
the rhodopsin template. As an increasing number of
experimentally determined structures become available
for the GPCR superfamily, template-based modeling
methods with limited ability in refinement will become
adequate for a larger proportion of the family. The de
novo modeling protocol presented here is expected to be
most useful in providing reliable models for those mem-
bers of the family that require significant refinement
from the best available template. Modeling the loops
accurately and predicting the agonist-induced conforma-
tional changes remain a formidable challenge in GPCR
structure prediction, and will require more experimental
structures before reliable models can be built.
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